Novel small-molecule modulators of GPR65
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT06634849
An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 4, 2024
Completion: Oct 30, 2027
Loading map...